Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

New family of gene-regulating enzymes discovered by Signal, Hebrew University

Jan. 7, 1999

U.S. patent issued to Millennium covers novel forms of caspase 8

Jan. 7, 1999

Sugen awarded U.S. patent for transcript imaging technology

Jan. 7, 1999

Telomerase expression extends lifespan of normal human cells without oncogenic transformation

Jan. 4, 1999

Modified TAPET organisms with tumor-targeting properties but reduced virulence and side effects

Dec. 30, 1998

Acquisition broadens Isis's antisense patent estate

Dec. 29, 1998

Biodiversity-related grant awarded to Xenova Discovery

Dec. 29, 1998

U.S. patent issued for primate embryonic stem cells; Geron holds license

Dec. 28, 1998

Four-year drug target collaboration signed by PPD and RPR

Dec. 28, 1998

Allelix and Lilly extend drug discovery alliance focusing on several therapeutic areas

Dec. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...